Cutting-Edge Research Capabilities BioModels boasts a state-of-the-art research facility with industry-leading technologies, such as HD video endoscopy, IVIS in-vivo imaging, and FlexiVent system. This advanced infrastructure and expertise enable the company to offer highly tailored and impactful preclinical contract research services to biotech and pharma companies.

Strategic Partnerships for Enhanced Services Through strategic collaborations with renowned researchers in various disease fields, BioModels ensures thoughtful study design and execution. These partnerships not only enhance the company's scientific credibility but also offer a network for potential collaboration opportunities with other players in the pharmaceutical and biotechnology sectors.

Microbiome Initiative Collaboration The recently launched Taconic-Biomodels Microbiome Initiative with Taconic Biosciences presents a prime opportunity for investigators to access comprehensive germ-free and gnotobiotic microbiome study solutions. This initiative not only showcases BioModels' commitment to innovation but also opens avenues for partnerships and service engagements within the microbiome research field.

Ideal for Personalized Drug Development With a focus on personalized service and clinically relevant disease models, BioModels is well-suited for biotech and pharma companies seeking bespoke preclinical efficacy studies. The company's decade-long experience in translating products from lab to clinic positions it as a valuable partner for organizations looking to accelerate their drug development pipelines.

Niche Market Domination & Competitive Edge In a market populated by similar entities like Biota Technology and BiomeSense, BioModels distinguishes itself through its specialized offerings and established expertise. Leveraging its resources, technology stack, and experience, BioModels has the potential to solidify its niche market dominance and attract clients looking for high-quality, tailored preclinical research services.